<DOC>
	<DOC>NCT01144273</DOC>
	<brief_summary>Randomized double blind placebo controlled trial on transversus abdominus plane block approached from abdominal cavity, in patients undergoing total abdominal hysterectomy.</brief_summary>
	<brief_title>Transversus Abdominis Plane Block From Abdominal Approach</brief_title>
	<detailed_description>Potential advantages compared to percutaneous approach are decrease in risk of visceral injury as it is under direct visual and tactile guidance, ease of approach in obese patients, short theatre time for administration, easy to administer.</detailed_description>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>ASA physical status IIII Age 18 or above Scheduled to undergo TAH+/ salpingoophorectomy. Scheduled to receive general anaesthesia under standardized anaesthetic regime. Comprehends how to use intravenous patient controlled analgesia (IV PCA). Is willing to complete the postoperative assessment. Understands the nature and purpose of this study and the study procedures and has signed the informed consent form for this study to indicate this understanding. Known allergy to drugs involved in this study Previously taking medications thought to result in opioid tolerance, or analgesics thought to interfere with subsequent opioid requirement. Undergoing any procedures in addition to TAH+/ salpingoophorectomy. With coexisting pathology resulting in persistent pain requiring analgesics. Wound incision extending to supraumbilical level.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>